How to buy Precipio stock - 24 Feb price $2.58 | finder.com

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Precipio stock | $2.58

Own Precipio stock in just a few minutes.

Precipio, Inc is a diagnostics & research business based in the US. Precipio shares (PRPO) are listed on the NASDAQ and all prices are listed in US Dollars. Precipio employs 54 staff and has a trailing 12-month revenue of around USD$6.1 million.

How to buy shares in Precipio

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Precipio. Find the stock by name or ticker symbol: PRPO. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Precipio reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$2.58, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Precipio, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Precipio. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Precipio share price

Use our graph to track the performance of PRPO stocks over time.

Precipio shares at a glance

Information last updated 2021-04-09.
Latest market closeUSD$2.58
52-week rangeUSD$0.55 - USD$5
50-day moving average USD$2.4749
200-day moving average USD$2.4149
Wall St. target priceUSD$6.65
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-5.807

Buy Precipio shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
N/A
A free way to invest in stocks, ETFs and crypto.
Robinhood
$0
Stocks, Options, ETFs, Gold/Commodities
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Precipio stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Precipio price performance over time

Historical closes compared with the close of $2.58 from 2021-02-25

1 week (2021-04-05) N/A
1 month (2021-03-16) 3.61%
3 months (2021-01-12) N/A
6 months (2020-10-12) N/A
1 year (2020-04-12) N/A
2 years (2019-04-12) N/A
3 years (2018-04-12) N/A
5 years (2016-04-12) N/A

Precipio financials

Revenue TTM USD$6.1 million
Gross profit TTM USD$1.2 million
Return on assets TTM -28.42%
Return on equity TTM -77.45%
Profit margin -174.41%
Book value $0.804
Market capitalisation USD$38.4 million

TTM: trailing 12 months

Shorting Precipio shares

There are currently 788,168 Precipio shares held short by investors – that's known as Precipio's "short interest". This figure is 16.9% down from 948,182 last month.

There are a few different ways that this level of interest in shorting Precipio shares can be evaluated.

Precipio's "short interest ratio" (SIR)

Precipio's "short interest ratio" (SIR) is the quantity of Precipio shares currently shorted divided by the average quantity of Precipio shares traded daily (recently around 410504.16666667). Precipio's SIR currently stands at 1.92. In other words for every 100,000 Precipio shares traded daily on the market, roughly 1920 shares are currently held short.

However Precipio's short interest can also be evaluated against the total number of Precipio shares, or, against the total number of tradable Precipio shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Precipio's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Precipio shares in existence, roughly 40 shares are currently held short) or 0.0453% of the tradable shares (for every 100,000 tradable Precipio shares, roughly 45 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Precipio.

Find out more about how you can short Precipio stock.

Precipio share dividends

We're not expecting Precipio to pay a dividend over the next 12 months.

Have Precipio's shares ever split?

Precipio's shares were split on a 1:15 basis on 28 April 2019. So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Precipio shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for Precipio shares which in turn could have impacted Precipio's share price.

Precipio share price volatility

Over the last 12 months, Precipio's shares have ranged in value from as little as $0.55 up to $5. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Precipio's is 2.8171. This would suggest that Precipio's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Precipio overview

Precipio, Inc., a cancer diagnostics and reagent technology company, provides diagnostic products and services in the United States oncology market. Its product consists of clinical diagnostic services. The company's clinical diagnostic services focus on the diagnosis of different hematopoietic or blood-related cancers to oncologists. Its cytogenetics media IV-Cell enables laboratories to arrive at more accurate results; HemeScreen panel enables hospitals and laboratories to run an important genetic mutation test; and ICE-COLD-PCR enables detection of abnormalities in blood samples. The company also operates a cancer diagnostic laboratory located in New Haven, Connecticut. It sells ICE-COLD-PCR technology kits to bio-pharma customers, clinical research, HemeScreen, and COVID-19 antibody tests. The company serves oncologists, hospitals, reference laboratories, physician-office labs, and pharma and biotech companies. Precipio, Inc. has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment, such as the Yale School of Medicine, Harvard's Dana-Farber Cancer Institute, and the University of Pennsylvania. The company is based in New Haven, Connecticut.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site